AHFS/Drugs.com Monograph Routes of
administration Nasal inhalation Molar mass 540.688 g/mol | MedlinePlus a607008 CAS ID 141845-82-1 | |
 | ||
Pregnancy
category AU: B3
US: C (Risk not ruled out) ATC code R01AD13 (WHO) R03BA08 (WHO) Legal status AU: S4 (Prescription only)
UK: POM (Prescription only)
US: ℞-only | ||
Ciclesonide is a glucocorticoid used to treat asthma and allergic rhinitis. It is marketed under the brand names Alvesco for asthma and Omnaris, Omniair, and Zetonna for hay fever in the US and Canada. Phase 3 trials for the hay fever indication outside of the US are ongoing. The drug was approved for adults and children 12 and over by the US Food and Drug Administration in October 2006. Side effects of the medication include headache, nosebleeds, and inflammation of the nose and throat linings.
References
Ciclesonide Wikipedia(Text) CC BY-SA